BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 19273282)

  • 1. Targeting the AMPK pathway for the treatment of Type 2 diabetes.
    Viollet B; Lantier L; Devin-Leclerc J; Hebrard S; Amouyal C; Mounier R; Foretz M; Andreelli F
    Front Biosci (Landmark Ed); 2009 Jan; 14(9):3380-400. PubMed ID: 19273282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.
    Viollet B; Mounier R; Leclerc J; Yazigi A; Foretz M; Andreelli F
    Diabetes Metab; 2007 Dec; 33(6):395-402. PubMed ID: 17997341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A spotlight on underlying the mechanism of AMPK in diabetes complications.
    Behl T; Gupta A; Sehgal A; Sharma S; Singh S; Sharma N; Diaconu CC; Rahdar A; Hafeez A; Bhatia S; Al-Harrasi A; Bungau S
    Inflamm Res; 2021 Sep; 70(9):939-957. PubMed ID: 34319417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases].
    Foretz M; Taleux N; Guigas B; Horman S; Beauloye C; Andreelli F; Bertrand L; Viollet B
    Med Sci (Paris); 2006 Apr; 22(4):381-8. PubMed ID: 16597407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural activators of adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) and their pharmacological activities.
    Vazirian M; Nabavi SM; Jafari S; Manayi A
    Food Chem Toxicol; 2018 Dec; 122():69-79. PubMed ID: 30290216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and fuel homeostasis: the role of AMP-activated protein kinase.
    Hegarty BD; Turner N; Cooney GJ; Kraegen EW
    Acta Physiol (Oxf); 2009 May; 196(1):129-45. PubMed ID: 19245658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting AMPK: From Ancient Drugs to New Small-Molecule Activators.
    Guigas B; Viollet B
    Exp Suppl; 2016; 107():327-350. PubMed ID: 27812986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMP-activated protein kinase: Role in metabolism and therapeutic implications.
    Schimmack G; Defronzo RA; Musi N
    Diabetes Obes Metab; 2006 Nov; 8(6):591-602. PubMed ID: 17026483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMP-activated protein kinase and metabolic control.
    Viollet B; Andreelli F
    Handb Exp Pharmacol; 2011; (203):303-30. PubMed ID: 21484577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapies of the LKB1/AMPK pathway for the treatment of insulin resistance.
    Yamada E; Lee TW; Pessin JE; Bastie CC
    Future Med Chem; 2010 Dec; 2(12):1785-96. PubMed ID: 21428801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthene derivatives increase glucose utilization through activation of LKB1-dependent AMP-activated protein kinase.
    Kwon Y; Song P; Yoon JH; Ghim J; Kim D; Kang B; Lee TG; Kim JA; Choi JK; Youn IK; Lee HK; Ryu SH
    PLoS One; 2014; 9(9):e108771. PubMed ID: 25250787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease.
    Grahame Hardie D
    J Intern Med; 2014 Dec; 276(6):543-59. PubMed ID: 24824502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients.
    Steneberg P; Lindahl E; Dahl U; Lidh E; Straseviciene J; Backlund F; Kjellkvist E; Berggren E; Lundberg I; Bergqvist I; Ericsson M; Eriksson B; Linde K; Westman J; Edlund T; Edlund H
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases.
    Srivastava RA; Pinkosky SL; Filippov S; Hanselman JC; Cramer CT; Newton RS
    J Lipid Res; 2012 Dec; 53(12):2490-514. PubMed ID: 22798688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of AMP kinase in diabetes.
    Misra P; Chakrabarti R
    Indian J Med Res; 2007 Mar; 125(3):389-98. PubMed ID: 17496363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [AMP-activated protein kinase (AMPK) as therapeutic target].
    Sarnowska E; Balcerak A; Olszyna-Serementa M; Kotlarek D; Sarnowski TJ; Siedlecki JA
    Postepy Hig Med Dosw (Online); 2013 Aug; 67():750-60. PubMed ID: 24018441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMP-activated protein kinase and its multifaceted regulation of hepatic metabolism.
    Fullerton MD
    Curr Opin Lipidol; 2016 Apr; 27(2):172-80. PubMed ID: 26906549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metformin and AMPK: an old drug and a new enzyme in the context of metabolic syndrome].
    Santomauro Júnior AC; Ugolini MR; Santomauro AT; Souto RP
    Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):120-5. PubMed ID: 18345405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niclosamide activates the AMP-activated protein kinase complex containing the β2 subunit independently of AMP.
    Suzuki T; Kojima M; Matsumoto Y; Kobayashi KI; Inoue J; Yamamoto Y
    Biochem Biophys Res Commun; 2020 Dec; 533(4):758-763. PubMed ID: 32993962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes.
    Musi N; Goodyear LJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):119-27. PubMed ID: 12476786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.